0.9936
price up icon3.10%   0.0299
 
loading

Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
14.42%
41.96
49.03 40.49 46.30 47.94
Interest Income/Expense
3.40%
3.129
3.239 3.343 3.429 3.50
Operating Income/Loss
14.42%
-41.96
-49.03 -40.49 -46.30 -47.94
Nonoperating Income/Loss
96.47%
0.031
0.879 0.482 3.804 -1.223
Income/Loss From Continuing Operations Before Tax
12.90%
-41.93
-48.14 -40.01 -42.50 -49.16
Income/Loss From Continuing Operations After Tax
12.90%
-41.93
-48.14 -40.01 -42.50 -49.16
Net Income/Loss
12.92%
-41.93
-48.15 -40.01 -42.50 -49.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
820.27%
225.74
24.53 192.88 95.45 94.87
Diluted Average Shares
820.27%
225.74
24.53 192.88 95.45 94.87
Basic Earnings Per Share
26.67%
-0.19
-0.15 -0.21 -0.45 -0.52
Diluted Earnings Per Share
26.67%
-0.19
-0.15 -0.21 -0.45 -0.52
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Kapitalisierung:     |  Volumen (24h):